Pacira BioSciences, Inc. PCRX Other — Due 2026
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PurchaseObligationDueInNextTwelveMonths.
The official record: Pacira BioSciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s other — due 2026.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s other — due 2026?
- Pacira BioSciences, Inc. (PCRX) reported other — due 2026 of $6.3M in Q4 2025.
- What does other — due 2026 mean?
- Represents the portion of contractual purchase obligations within the 'Other' business segment that are scheduled for payment during the fiscal year 2026. This metric provides visibility into the company's near-term liquidity requirements and contractual liabilities. It allows stakeholders to evaluate the timing of cash outflows relative to projected revenue streams for this specific segment.